These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35163322)

  • 1. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.
    Kim JS; Lee KB; Park JH; Sung SM; Oh K; Kim EG; Chang DI; Hwang YH; Lee EJ; Kim WK; Ju C; Kim BS; Ryu JM;
    Ann Neurol; 2020 Feb; 87(2):233-245. PubMed ID: 31721277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X; Chu H; Tang Y; Dong Q
    Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
    Huang Y; Gu S; Han Z; Yang Z; Zhong L; Li L; Wang R; Yan F; Luo Y; Borlongan C; Lu J
    J Am Heart Assoc; 2023 Sep; 12(17):e029817. PubMed ID: 37655472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
    Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
    Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
    Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
    Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
    Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
    He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
    Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.
    Liu R; Liu Q; He S; Simpkins JW; Yang SH
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1006-12. PubMed ID: 19952306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.